semaglutide compound deaths Off-Label Linked to Deaths, Hospitalizations Calling for Compounding Regulation Semaglutide Patient Safety Updates |

[2] When to seek urgent advice: Contact your GP or healthcare provider promptly if you: Suspect you may be pregnant whilst taking GLP-1 medication Experience sudden changes in menstrual patterns Develop severe abdominal pain (especially if radiating to the back), persistent vomiting, or signs of gallbladder problems Experience severe, persistent vomiting or diarrhoea leading to dehydration Your healthcare team can coordinate care between endocrinology, gynaecology, and fertility services as needed, ensuring that your weight management and reproductive health goals are addressed safely and effectively

A retrospective cohort study on the effects of glucagon-like peptide 1 receptor agonist use on the risk of different obesity-associated malignancies

According to WW, Med+ members prescribed GLP-1 medications lost an average of 7.4 lbs in the first four weeks

Step 2 pick your weekly dose

References: -Frias JP, Hsia S, Eyde S, et al

Neurotherapeutics 22 (3), e00525